1. Estrogenic effects of flavonoid components in Xiaoyao powder.
- Author
-
Chen JH, Zhang N, Wang YQ, Wang JZ, Ji SX, Dang WJ, Li SM, and Feng L
- Subjects
- Antineoplastic Agents pharmacology, Cell Proliferation drug effects, Estrogen Receptor alpha agonists, Estrogen Receptor alpha metabolism, Estrogen Receptor beta agonists, Estrogen Receptor beta metabolism, Folic Acid analogs & derivatives, Folic Acid pharmacology, Gene Expression Regulation, Neoplastic, Humans, Kaempferols antagonists & inhibitors, MCF-7 Cells, Powders chemistry, Quercetin antagonists & inhibitors, RNA, Messenger agonists, RNA, Messenger metabolism, Signal Transduction, Drugs, Chinese Herbal chemistry, Estrogen Receptor alpha genetics, Estrogen Receptor beta genetics, Kaempferols pharmacology, Quercetin analogs & derivatives, Quercetin pharmacology, RNA, Messenger genetics
- Abstract
The objective of this study was to evaluate the estrogenic effects and mechanisms of three flavonoid components in Xiaoyao powder: quercetin, kaempferol, and isorhamnetin. The drugs were used to treat estrogen receptor (ER)-positive human breast cancer MCF-7 cells, and proliferation was measured using the MTT method. The expression of proteins and mRNA of the ER subtype were measured using western blotting and real time polymerase chain reaction. The quercetin (10(-2) μM, 10(-3) μM), kaempferol (100 μM, 10(-2) μM), and isorhamnetin (10(-3) μM) promoted the proliferation of MCF-7 cells, and the expression of ERα and ERβ proteins and mRNA were all increased significantly (P < 0.05). These effects were reversed by treatment with 0.1 μM estrogen antagonist ICI182780. Three flavonoid components in Xiaoyao powder increased the expression of proteins and mRNA of ERα and ERβ and promoted the proliferation of MCF-7 cells. These estrogenic effects were mediated by the ER.
- Published
- 2016
- Full Text
- View/download PDF